Identification of Unapproved Orthopedic Regenerative Medicine: Usefulness of the Act on Safety of Regenerative Medicine

Yuichiro Ukon,Satoshi Hosoya, Kazuki Morita,Yuji Yokozeki,Tomoko Kataoka,Takayuki Kitahara,Hirokazu Mae,Yuya Kanie,Masayuki Furuya,Takahito Fujimori,Takashi Kaito,Kiyoshi Okada,Akira Myoui,Seiji Okada

STEM CELL REPORTS（2024）

引用 0|浏览5

暂无评分

摘要

In Japan, the Act on Safety of Regenerative Medicine regulates unapproved regenerative medicine. Other nations market regenerative medicine products, bypassing regulatory approval. To identify unapproved orthopedic regenerative medicine, we have used data based on the Act. Platelet-rich plasma was often used. The common target was the knee. Prices averaged $2,490.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要